Daiwa Securities Group’s Genomic Health, Inc. GHDX Stock Holding History

Daiwa Securities Group’s Portfolio GHDX Stock Details GHDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-235	Closed	-$16K	–	1275
2019 Q3	$16K	Hold	235	–	–	﹤0.01%	1005
2019 Q2	$14K	Hold	235	–	–	﹤0.01%	1040
2019 Q1	$16K	Buy	235 +43	+22%	+$3.19K	﹤0.01%	1004
2018 Q4	$12K	Hold	192	–	–	﹤0.01%	989
2018 Q3	$13K	Hold	192	–	–	﹤0.01%	1022
2018 Q2	$10K	Hold	192	–	–	﹤0.01%	1056
2018 Q1	$6K	Buy	+192	New	+$6.37K	﹤0.01%	1069

Daiwa Securities Group's GHDX Position: Q4 2019 in Review

Daiwa Securities Group sold out of Genomic Health, Inc. (GHDX) in Q4 2019, closing a stake of 235 shares — an estimated $16K sold.

Daiwa Securities Group first reported a position in GHDX in Q1 2018 and held it in 7 quarters. The position peaked at $16K in Q3 2019. 0 funds tracked by Wall St. Rank hold GHDX as of Q4 2019.

Daiwa Securities Group reported no remaining Genomic Health, Inc. position as of Q4 2019 after selling out during the quarter.
Daiwa Securities Group sold 235 Genomic Health, Inc. shares in Q4 2019, an estimated $16K.
Daiwa Securities Group first reported a position in Genomic Health, Inc. in Q1 2018 and held it in 7 quarters.
Daiwa Securities Group's Genomic Health, Inc. position peaked at $16K in Q3 2019.
0 funds tracked by Wall St. Rank held Genomic Health, Inc. as of Q4 2019.

Based on Daiwa Securities Group's 13F filing for Q4 2019, filed 31 Jan 2020.